195 related articles for article (PubMed ID: 2360804)
21. Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient.
Kompoliti K; Chu Y; Shannon KM; Kordower JH
Mov Disord; 2007 Aug; 22(11):1630-3. PubMed ID: 17534949
[TBL] [Abstract][Full Text] [Related]
22. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers.
Bohn MC; Cupit L; Marciano F; Gash DM
Science; 1987 Aug; 237(4817):913-6. PubMed ID: 2887034
[TBL] [Abstract][Full Text] [Related]
23. [Adrenal transplantation and Parkinson's disease].
Luquin MR; Legarda I; Guillén J; Rodríguez MC; Martínez-Lage JM
Rev Med Univ Navarra; 1994; 38(4):174-80. PubMed ID: 8992595
[TBL] [Abstract][Full Text] [Related]
24. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study.
Watts RL; Subramanian T; Freeman A; Goetz CG; Penn RD; Stebbins GT; Kordower JH; Bakay RA
Exp Neurol; 1997 Oct; 147(2):510-7. PubMed ID: 9344575
[TBL] [Abstract][Full Text] [Related]
25. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
26. NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells.
Kordower JH; Fiandaca MS; Notter MF; Hansen JT; Gash DM
J Neurosurg; 1990 Sep; 73(3):418-28. PubMed ID: 2384781
[TBL] [Abstract][Full Text] [Related]
27. Adrenal medullary autografts in anterior eye chamber, lateral ventricle and striatum of adult rats: a long term study.
Shetty AK; Gopinath G; Tandon PN
J Neural Transplant Plast; 1991; 2(3-4):175-91. PubMed ID: 1685897
[TBL] [Abstract][Full Text] [Related]
28. Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice.
Date I; Felten SY; Olschowka JA; Felten DL
Exp Neurol; 1990 Mar; 107(3):197-207. PubMed ID: 2307201
[TBL] [Abstract][Full Text] [Related]
29. Expanded mesencephalic precursors develop into grafts of densely packed dopaminergic neurons that reinnervate the surrounding striatum and induce functional responses in the striatal neurons.
Rodriguez-Pallares J; Parga JA; Rey P; Guerra MJ; Labandeira-Garcia JL
Synapse; 2005 Oct; 58(1):13-22. PubMed ID: 16037947
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
[TBL] [Abstract][Full Text] [Related]
31. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
[TBL] [Abstract][Full Text] [Related]
32. Dopaminergic innervation of the human striatum in Parkinson's disease.
Porritt M; Stanic D; Finkelstein D; Batchelor P; Lockhart S; Hughes A; Kalnins R; Howells D
Mov Disord; 2005 Jul; 20(7):810-8. PubMed ID: 15726582
[TBL] [Abstract][Full Text] [Related]
33. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
[TBL] [Abstract][Full Text] [Related]
34. Striatal dopaminergic neurons are lost with Parkinson's disease progression.
Porritt MJ; Kingsbury AE; Hughes AJ; Howells DW
Mov Disord; 2006 Dec; 21(12):2208-11. PubMed ID: 17029264
[TBL] [Abstract][Full Text] [Related]
35. [Where are the grafts in Parkinson's disease?].
Goetz CG
Rev Prat; 1989 Mar; 39(8):675-7. PubMed ID: 2727574
[TBL] [Abstract][Full Text] [Related]
36. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
[TBL] [Abstract][Full Text] [Related]
37. CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.
Riederer P; Rausch WD; Birkmayer W; Jellinger K; Seemann D
J Neural Transm Suppl; 1978; (14):121-31. PubMed ID: 39974
[TBL] [Abstract][Full Text] [Related]
38. [Intracaudate grafting of the adrenal medulla in the treatment of Parkinson's disease].
Zhang WC; Ding MC; Jiao SS
Zhonghua Wai Ke Za Zhi; 1988 Jan; 26(1):1-5, 59. PubMed ID: 3197528
[No Abstract] [Full Text] [Related]
39. Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures.
Carvey PM; Ptak LR; Nath ST; Sierens DK; Mufson EJ; Goetz CG; Klawans HL
Exp Neurol; 1993 Mar; 120(1):149-52. PubMed ID: 8097475
[TBL] [Abstract][Full Text] [Related]
40. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Agrawal AK
Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
